Bioforce Nanosciences Holdings, Inc.
BFNH· OTC
BFNHBioforce Nanosciences Holdings, Inc.
Filed Feb 11, 2022 · 10-K · 42 days after period end · 0001091818-22-000014
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | $1.00 | — |
| Net Income | -$120.70K | -$122.57K | -$20.17K | -$8.59K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioforce Nanosciences Holdings, Inc. · CIK 1310488 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Feb 11, 2022 · 42 d after period end
